Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Continuous Glucose Monitoring Market Revenue Growth On Track For A 14.8% CAGR Through 2030#_x000D_
The continuous glucose monitoring market has experienced substantial expansion in recent years. It is projected to increase from $9.44 billion in 2025 to $10.87 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.1%. The market’s historical growth can be attributed to several factors, including the initial limited availability of real-time glucose monitoring devices, the high cost associated with early continuous glucose monitors (CGMs), increasing awareness regarding diabetes management, the prevalent dependence on finger-prick testing, and the rising adoption of monitoring solutions within hospitals._x000D_
_x000D_
The continuous glucose monitoring market is projected to experience substantial expansion over the upcoming years, reaching $18.86 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.8%. This anticipated growth during the forecast timeframe is attributable to several factors, including advancements in wearable and implantable sensor technology, the integration of these systems with mobile health and telemedicine platforms, the increasing global incidence of diabetes, the emergence of non-invasive glucose monitoring solutions, and the broadening reach of home healthcare and remote patient monitoring services. Key trends anticipated for the forecast period encompass a greater uptake of continuous glucose monitoring devices by individuals with diabetes, ongoing innovation in minimally invasive and implantable sensor designs, the incorporation of real-time data analysis and alert functionalities, the expansion of home-based monitoring and telehealth options, and an increasing need for glucose monitoring solutions tailored for both pediatric and geriatric populations._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Continuous Glucose Monitoring Market Growth Catalysts And Demand Drivers#_x000D_
The increasing incidence of diabetes is projected to drive the expansion of the continuous glucose monitoring market in the future. Diabetes is a chronic medical condition characterized by the body’s inability to produce sufficient insulin or to utilize the insulin it does produce efficiently, leading to elevated blood sugar (glucose) levels. The growing occurrence of diabetes is largely attributable to poor dietary habits, including foods rich in sugars, fats, and processed ingredients, which are factors in obesity and dysfunctional insulin action. Continuous glucose monitoring aids in managing diabetes by offering immediate insights into blood sugar patterns, thereby facilitating prompt choices regarding diet, medication, and physical activity for improved glucose regulation. As an illustration, the National Health Service, a UK-based government body, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) had been diagnosed with non-diabetic hyperglycemia or pre-diabetes (a state where blood sugar levels are high but not severe enough to be diabetes) in 2023. This represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of diabetes is a key factor propelling the expansion of the continuous glucose monitoring market._x000D_
_x000D_
#Continuous Glucose Monitoring Market Breakdown By Product Type And Application#_x000D_
The continuous glucose monitoring market covered in this report is segmented – _x000D_
_x000D_
1) By Component: Transmitters, Sensors, Receivers_x000D_
2) By Age Group: Adults, Children_x000D_
3) By End Use: Hospitals, Home Care Settings, Diagnostic Centers And Clinics, Other End Uses_x000D_
_x000D_
Subsegments:_x000D_
1) By Transmitters: Reusable Transmitters, Disposable Transmitters, Rechargeable Transmitters_x000D_
2) By Sensors: Implantable Sensors, Transcutaneous Sensors, Disposable Sensors, Real-Time Sensors_x000D_
3) By Receivers: Standalone Receivers, Integrated Receivers, Wearable Display Devices_x000D_
_x000D_
#Continuous Glucose Monitoring Market Trends Shaping Long-Term Demand#_x000D_
Leading corporations within the continuous glucose monitoring market are prioritizing the development of innovative products, such as sensor-based glucose monitors, to improve accuracy, facilitate real-time tracking, and enhance patient convenience. These sensor-based glucose monitors are devices that continuously measure blood sugar levels using a small sensor positioned beneath the skin. For instance, in August 2024, DexCom, Inc., a US-based healthcare company, introduced Stelo, which stands as the first over-the-counter (OTC) continuous glucose monitor (CGM) specifically designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings through a compact sensor worn on the back of the upper arm, with data transmitted directly to a smartphone, eliminating the need for a prescription or fingersticks. The device offers personalized insights and trend analysis, helping users understand the impact of factors like diet, exercise, and sleep on their glucose levels, thus empowering smarter lifestyle choices. The sensor functions for up to 15 days, integrates with health apps, and is ideally suited for individuals with Type 2 diabetes not on insulin, those with prediabetes, or anyone monitoring their glucose health._x000D_
_x000D_
#Continuous Glucose Monitoring Market Key Players Shaping Industry Direction#_x000D_
Major companies operating in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd _x000D_
_x000D_
#View The Full Continuous Glucose Monitoring Market Report:#_x000D_
_x000D_
#Continuous Glucose Monitoring Market Regional Analysis: Which Geography Leads On Revenue?#_x000D_
North America was the largest region in the continuous glucose monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
